These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1311962)

  • 41. Prevalence of antibody to hepatitis C virus in hemodialysis patients.
    Hayashi J; Nakashima K; Kajiyama W; Noguchi A; Morofuji M; Maeda Y; Kashiwagi S
    Am J Epidemiol; 1991 Sep; 134(6):651-7. PubMed ID: 1659184
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evidence against transmission of hepatitis C virus through hemodialysis ultrafiltrate and peritoneal fluid.
    Caramelo C; Navas S; Alberola ML; Bermejillo T; Reyero A; Carreño V
    Nephron; 1994; 66(4):470-3. PubMed ID: 7517019
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Relative risk of hepatitis C virus transmission in polytransfused patients].
    Schujman L; Lavitula S; Maris Acebal S; Suita GR; Montero A
    Medicina (B Aires); 1994; 54(3):199-202. PubMed ID: 7854084
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antibodies against hepatitis C virus in hemodialysis patients in the central Italian region of Umbria: evaluation of some risk factors.
    Brugnano R; Francisci D; Quintaliani G; Gaburri M; Nori G; Verdura C; Giombini L; Buoncristiani U
    Nephron; 1992; 61(3):263-5. PubMed ID: 1323768
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatitis C-virus (HCV) antibodies in patients after kidney transplantation.
    Baur P; Daniel V; Pomer S; Scheurlen H; Opelz G; Roelcke D
    Ann Hematol; 1991; 62(2-3):68-73. PubMed ID: 1851645
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatitis C virus in dialysis units: a multicenter study.
    Da Porto A; Adami A; Susanna F; Calzavara P; Poli P; Castelletto MR; Amici GP; Teodori T; Okolicsanyi L
    Nephron; 1992; 61(3):309-10. PubMed ID: 1323777
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatitis G virus infection in hemodialysis and continuous ambulatory peritoneal dialysis patients.
    Noh H; Kang SW; Choi SH; Shin SK; Seo BJ; Lee IH; Choi KH; Han DS; Kim HS; Lee HY
    Yonsei Med J; 1998 Apr; 39(2):116-21. PubMed ID: 9587251
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence of hepatitis C virus (HCV) infection and HCV genotypes of hemodialysis patients in Salvador, Northeastern Brazil.
    Silva LK; Silva MB; Rodart IF; Lopes GB; Costa FQ; Melo ME; Gusmão E; Reis MG
    Braz J Med Biol Res; 2006 May; 39(5):595-602. PubMed ID: 16648896
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Prevention of post-transfusion non-A, non-B hepatitis by anti-HCV screening].
    Holzberger G; Seidl S; Peschke B; Scheuermann EH; Schoeppe W
    Infusionsther Transfusionsmed; 1992 Jun; 19(3):157-9. PubMed ID: 1379861
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of hepatitis C virus antibodies in hemodialysis patients and dialysis staff.
    Fujiyama S; Kawano S; Sato S; Tanaka M; Goto M; Taura Y; Sato T; Kawahara T; Mizuno K
    Hepatogastroenterology; 1992 Apr; 39(2):161-5. PubMed ID: 1378811
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence of non-A non-B hepatitis and anti-HCV antibodies in a Portuguese dialysis population.
    Carrera F; Silva JG; Pires C; Oliveira C
    Nephrol Dial Transplant; 1992; 7(9):913-6. PubMed ID: 1383874
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The prevalence of antibody to hepatitis C virus in a dialysis population.
    Hay NM; Lynn KL; Schousboe MI
    N Z Med J; 1992 Apr; 105(931):134. PubMed ID: 1373230
    [No Abstract]   [Full Text] [Related]  

  • 53. The prevalence of hepatitis C virus antibodies among hemodialysis patients.
    Zeldis JB; Depner TA; Kuramoto IK; Gish RG; Holland PV
    Ann Intern Med; 1990 Jun; 112(12):958-60. PubMed ID: 2111110
    [No Abstract]   [Full Text] [Related]  

  • 54. High prevalence of hepatitis C infection among Brazilian hemodialysis patients in Rio de Janeiro: a one-year follow-up study.
    Vanderborght BO; Rouzere C; Ginuino CF; Maertens G; Van Heuverswyn H; Yoshida CF
    Rev Inst Med Trop Sao Paulo; 1995; 37(1):75-9. PubMed ID: 7569645
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Incidence and risk factors for hepatitis C seroconversion in hemodialysis: a prospective study. The UCL Collaborative Group.
    Jadoul M; Cornu C; van Ypersele de Strihou C
    Kidney Int; 1993 Dec; 44(6):1322-6. PubMed ID: 7508005
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High prevalence of antibodies to hepatitis C virus in hemodialysis units using a second generation assay.
    Mondelli MU; Cristina G; Piazza V; Cerino A; Villa G; Salvadeo A
    Nephron; 1992; 61(3):350-1. PubMed ID: 1323788
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatitis C virus in chronic dialysis patients.
    Natov SN; Pereira BJ
    Minerva Urol Nefrol; 2005 Sep; 57(3):175-97. PubMed ID: 15986016
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence and risk factors for hepatitis C virus infection in continuous ambulatory peritoneal dialysis patients.
    Górriz JL; Miguel A; García-Ramón R; Pérez-Contreras J; Olivares J; Gómez-Roldán C; Alvariño J; Lanuza M
    Nephrol Dial Transplant; 1996 Jun; 11(6):1109-12. PubMed ID: 8671977
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Anti-HCV antibodies among hemodialysed and kidney-transplanted patients].
    Juszczyk J; Flieger J; Syczewska M; Krzymański M
    Przegl Epidemiol; 1994; 48(1-2):3-9. PubMed ID: 8073139
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High prevalence of hepatitis C infection among patients receiving hemodialysis at an urban dialysis center.
    Sivapalasingam S; Malak SF; Sullivan JF; Lorch J; Sepkowitz KA
    Infect Control Hosp Epidemiol; 2002 Jun; 23(6):319-24. PubMed ID: 12083235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.